Clinical Significance of Vascular Endothelial Growth Factor C Expression and Angiogenesis at the Deepest Invasive Site of Advanced Colorectal Carcinoma
- 1 March 2002
- journal article
- Published by S. Karger AG in Oncology
- Vol. 62 (2) , 157-166
- https://doi.org/10.1159/000048262
Abstract
Aim: Vascular endothelial growth factor C (VEGF-C) is known to be associated with the development of the lymphatic vascular system. The aim of this study was to elucidate the clinical significance of VEGF-C expression and microvessel density (MVD) at the deepest invasive site in advanced colorectal carcinoma (CRC). Methods: 152 patients who had undergone surgical resection for advanced CRC entered this study. VEGF-C expression was examined immunohistochemically with anti-VEGF-C polyclonal antibody C-20. Tumor MVD was determined immunohistochemically with anti-CD34 antibody. VEGF-C expression was defined as positive if distinct staining of the cytoplasm was observed in at least 10% of tumor cells at the deepest invasive site, central portion and superficial part of the tumor. MVD was estimated by averaging the count of three ×400 fields in the most vascular area at the deepest invasive site. Results: VEGF-C expression was detected in 71 of 152 lesions (46.7%) at the deepest invasive site. VEGF-C expression correlated significantly with poorer histologic grade, depth of invasion, lymphatic invasion, lymph node metastasis, venous invasion, liver metastasis and Duke’s stage. At the central portion and superficial part, there were no significant differences between VEGF-C expression and clinicopathological findings. VEGF-C expression at the deepest invasive site also correlated significantly with MVD. In cases with curative surgery, patients with VEGF-C expression at the deepest invasive site had a significantly poorer prognosis than those without VEGF-C expression. Furthermore, prognosis for patients with both VEGF-C expression and high MVD at the deepest invasive site was significantly poorer than that of patients without VEGF-C expression and with low MVD. Multivariate analysis with logistic regression for 5-year survival in patients with curative surgery showed that lymph node metastasis and VEGF-C expression were significant risk factors. Conclusions: VEGF-C expression at the deepest site of tumor invasion can be a useful predictor of poor prognosis in advanced CRC and show a close relation to angiogenesis.Keywords
This publication has 11 references indexed in Scilit:
- Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissuesBritish Journal of Cancer, 2000
- VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumoursBritish Journal of Cancer, 1999
- Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasisBritish Journal of Cancer, 1999
- A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinasesThe EMBO Journal, 1999
- Proteolytic processing regulates receptor specificity and activity of VEGF-CThe EMBO Journal, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Vascular endothelial growth factor B, a novel growth factor for endothelial cells.Proceedings of the National Academy of Sciences, 1996
- Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.Proceedings of the National Academy of Sciences, 1996
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992